FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 67 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2018. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $0 | -100.0% | 34,000 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $113,000 | +9.7% | 34,000 | 0.0% | 0.05% | +5.9% |
| Q3 2019 | $103,000 | +27.2% | 34,000 | 0.0% | 0.05% | +15.9% |
| Q2 2019 | $81,000 | -36.7% | 34,000 | 0.0% | 0.04% | -35.3% |
| Q1 2019 | $128,000 | +4.9% | 34,000 | 0.0% | 0.07% | -13.9% |
| Q4 2018 | $122,000 | -60.5% | 34,000 | -37.0% | 0.08% | -51.5% |
| Q3 2018 | $309,000 | – | 54,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,293,177 | $4,643,000 | 4.08% |
| GREAT POINT PARTNERS LLC | 4,047,561 | $14,531,000 | 1.84% |
| Sio Capital Management, LLC | 1,151,510 | $4,134,000 | 1.51% |
| DAFNA Capital Management LLC | 808,000 | $2,901,000 | 1.44% |
| Diag Capital Management, LP | 146,432 | $960,000 | 1.10% |
| Perceptive Advisors | 4,661,824 | $15,850,000 | 0.60% |
| Eversept Partners, LP | 294,660 | $1,057,829 | 0.57% |
| Sofinnova Investments, Inc. | 832,293 | $2,987,000 | 0.37% |
| KNOTT DAVID M | 206,200 | $740,000 | 0.35% |
| Orbimed Advisors | 5,195,330 | $18,651,000 | 0.34% |